Target intelligence / Profile preview

Host regenerative and stromal cells via PDLSC-secreted growth factors and their receptors

Molecular classification
Growth factor, Receptor, Cytokine, Other
01

Overview

The term Host regenerative and stromal cells via PDLSC-secreted growth factors and their receptors refers to a complex paracrine signaling axis rather than a single molecular target. Periodontal Ligament Stem Cells (PDLSCs) are multipotent mesenchymal stem cells that play a pivotal role in the maintenance and regeneration of periodontal tissues by secreting a diverse array of growth factors, such as Vascular Endothelial Growth Factor (VEGF), Hepatocyte Growth Factor (HGF), and Transforming Growth Factor-beta (TGF-beta) [PMID: 31464478]. These secreted factors interact with their cognate receptors on neighboring host cells, including endothelial cells, osteoblasts, and immune cells, to stimulate biological processes essential for tissue engineering, such as angiogenesis, cell migration, and osteogenic differentiation [PMID: 33061988]. This mechanism is a primary focus in regenerative medicine for treating periodontitis and alveolar bone defects, where the PDLSC secretome is being explored as a cell-free therapeutic alternative to direct stem cell transplantation [PMID: 28210531]. Because this entry encompasses a broad network of ligands and receptors across multiple cell types, it is classified as a biological pathway or therapeutic mechanism rather than a discrete drug target [PMID: 30101505].

Other names
PDLSC secretomePeriodontal ligament stem cell paracrine signalingPDLSC-mediated tissue regenerationPDLSC-derived growth factor signaling
02

Mechanism of action

Periodontal Ligament Stem Cells (PDLSCs) secrete a variety of bioactive molecules, including growth factors and cytokines, which bind to specific receptors on host regenerative and stromal cells to activate signaling pathways that promote tissue repair, angiogenesis, and immunomodulation.

03

Biological functions

Signal transductionCell proliferationAngiogenesisTissue regenerationImmune responseOsteogenesis
04

Disease associations

InflammationPeriodontitisBone lossOther
05

Safety considerations

Potential for ectopic tissue formationTheoretical risk of promoting tumor growth via pro-angiogenic factorsStandardization and quality control of secretome compositionImmunogenicity of secretome components in heterologous applications
06

Biomarkers

Vascular endothelial growth factor (VEGF)Hepatocyte growth factor (HGF)Transforming growth factor beta 1 (TGF-beta1)Insulin-like growth factor 1 (IGF-1)CD90CD105CD73

Beyond the preview

Go deeper on Host regenerative and stromal cells via PDLSC-secreted growth factors and their receptors.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Host regenerative and stromal cells via PDLSC-secreted growth factors and their receptors.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call